Capital Performance Advisors’s Nu Skin NUS Stock Holding History

Capital Performance Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-136	Closed	-$1K	–	1822
2024 Q3	$1K	Buy	+136	New	+$1.27K	﹤0.01%	1904

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital Performance Advisors's NUS Position: Q4 2024 in Review

Capital Performance Advisors sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 136 shares — an estimated $1K sold.

Capital Performance Advisors first reported a position in NUS in Q3 2024 and held it in 1 quarter. The position peaked at $1K in Q3 2024. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

Capital Performance Advisors reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 136 Nu Skin shares in Q4 2024, an estimated $1K.
Capital Performance Advisors first reported a position in Nu Skin in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's Nu Skin position peaked at $1K in Q3 2024.
200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.